Dapsone-induced hepatic complications: it’s time to think beyond methemoglobinemia

References

• Ahmad, R.A., and Rogers, H.J., 1980. Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine. British Journal of Clinical Pharmacology, 10(5), 519–524.
   PubMed Web of Science ®Google Scholar
• Barnes, J., and Barnes, E.J., 1951. Liver damage during treatment with diaminodiphenylsulfone. Leprosy Review, 22(2), 54–56.
   PubMedGoogle Scholar
• Buttle, G.A.H., et al., 1937. The treatment of streptococcal infections in mice with 4:2′diaminodiphenylsulfone. The Lancet, 229(5936), 1331–1334.
   Google Scholar
• Casaril, M., et al., 2000. Role of iron load on fibrogenesis in chronic hepatitis C. Hepatogastroenterology, 47(31), 220–225.,
   PubMedGoogle Scholar
• Chougule, M., Padhi, B., and Misra, A., 2008. Development of spray dried liposomal dry powder inhaler of dapsone. AAPS Pharmscitech, 9(1), 47–53.
   PubMed Web of Science ®Google Scholar
• Ciccoli, L., et al., 1999. Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver. Toxicology Letters, 110(1–2), 57–66.
   PubMed Web of Science ®Google Scholar
• Coleman, M.D., 1993. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. British Journal of Dermatology, 129(5), 507–513.
   PubMed Web of Science ®Google Scholar
• Coleman, M.D., 2001. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. Toxicology, 162(1), 53–60.
   PubMed Web of Science ®Google Scholar
• Das, A.K., and Jawed, Q., 2014. Drug-induced acute pancreatitis: a rare manifestation of an incomplete “dapsone syndrome”. Indian Journal of Pharmacology, 46(4), 455–457.
   PubMed Web of Science ®Google Scholar
• Devarbhavi, H., et al., 2010. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. American Journal of Gastroenterology, 105(11), 2396–2404.
   PubMed Web of Science ®Google Scholar
• Devarbhavi, H., et al., 2017. Features and treatment of Dapsone-Induced hepatitis, based on analysis of 44 cases and literature review. Clinical Gastroenterology and Hepatology, 15(11), 1805–1807.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan, D., 2018. Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective. Arab Journal of Gastroenterology, 19(2), 56–64.
   PubMed Web of Science ®Google Scholar
• Fromm, E., and Wittmann, J., 1908. Derivate des p-nitrothiophenols. Berichte Der Deutschen Chemischen Gesellschaft, 41(2), 2264–2273.
   Google Scholar
• Goette, D.K., 1977. Dapsone-induced hepatic changes. Archives of Dermatology, 113(11), 1616–1617.
   PubMedGoogle Scholar
• Hoofnagle, J.H., and Björnsson, E.S., 2019. Drug-Induced liver Injury – Types and phenotypes. New England Journal of Medicine, 381(3), 264–273.
   PubMed Web of Science ®Google Scholar
• Iorga, A., and Dara, L.2., 2019. Cell death in drug-induced liver injury. Advances in Pharmacology (San Diego, Calif.), 85, 31–74.
   PubMedGoogle Scholar
• Irshaid, Y., et al., 1994. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes. Drug Metabolism and Disposition, 22(1), 161–164.
   PubMed Web of Science ®Google Scholar
• Itha, S., et al., 2003. Dapsone induced cholangitis as a part of dapsone syndrome: a case report. BMC Gastroenterology, 3(1), 21.
   PubMed Web of Science ®Google Scholar
• Jaiprakash, H., Narayana, S., and Mohanraj, J., 2012. Drug-induced hepatotoxicity in a tertiary care hospital in rural South India. North American Journal of Medical Sciences, 4, 90–93.
   PubMedGoogle Scholar
• Kannan, G., et al., 2009. Drug usage evaluation of dapsone. Indian Journal of Pharmaceutical Sciences, 71(4), 456–460.
   PubMed Web of Science ®Google Scholar
• Kirby, B., et al., 1999. Abnormal liver function tests induced by dapsone in a patient with dermatitis herpetiformis and primary sclerosing cholangitis. British Journal of Dermatology, 141, 172–173.
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick, G.A., et al., 2017. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut, 66(6), 1154–1164.
   PubMed Web of Science ®Google Scholar
• Lau, G., 1995. A fatal case of drug-induced multi-organ damage in a patient with Hansen's disease: dapsone syndrome or rifampicin toxicity? Forensic Science International, 73(2), 109–115.
   PubMed Web of Science ®Google Scholar
• Paniker, U., and Levine, N., 2001. Dapsone and sulfapyridine. Dermatologic Clinics, 19(1), 79–86.
   PubMed Web of Science ®Google Scholar
• Prasad, P., 2000. A study of dapsone syndrome at a rural teaching hospital in South India. Indian Journal of Dermatology, Venereology and Leprology, 66, 136–138.
   PubMedGoogle Scholar
• Semira,  , Wafai, Z.A., et al., 2014. Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria. Indian Journal of Pharmacology, 46, 438–440.
   PubMed Web of Science ®Google Scholar
• Stone, S.P., and Goodwin, R.M., 1978. Dapsone-induced jaundice. Archives of Dermatology, 114(6), 947.
   PubMedGoogle Scholar
• Swathi, M., 2014. A study of liver function tests in leprosy. Indian Journal of Leprosy, 86(4), 155–159.
   PubMedGoogle Scholar
• Tingle, M.D., et al., 1997. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man. The Journal of Pharmacology and Experimental Therapeutics, 283(2), 817–823.
   PubMed Web of Science ®Google Scholar
• Veggi, L.M., et al., 2002. Dapsone-induced cholestasis and impairment of bile salt output in the rat. Biochemical Pharmacology, 63(8), 1553–1563.
   PubMed Web of Science ®Google Scholar
• Veggi, L.M., et al., 2005. Dapsone impairs the bile salt-independent fraction of bile flow in rats: Possible involvement of its N-hydroxylated metabolite. Toxicology, 211(1–2), 97–106.
   PubMed Web of Science ®Google Scholar
• Veggi, L.M., et al., 2008. Dapsone induces oxidative stress and impairs antioxidant defenses in rat liver. Life Sciences, 83(5–6), 155–163.
   PubMed Web of Science ®Google Scholar
• Wozel, G., and Blasum, C., 2014. Dapsone in dermatology and beyond. Archives of Dermatological Research, 306(2), 103–124.
   PubMed Web of Science ®Google Scholar
• Zhu, Y.I., and Stiller, M.J., 2001. Dapsone and sulfones in dermatology: overview and update. Journal of the American Academy of Dermatology, 45(3), 420–434.
   PubMed Web of Science ®Google Scholar
• Zimmerman, H. J., 1999. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott Williams & Wilkins.
   Google Scholar
• Zou, D.M., and Sun, W.L., 2017. Relationship between Hepatitis C Virus Infection and Iron Overload. Chinese Medical Journal (Journal), 130(7), 866–871.
   PubMed Web of Science ®Google Scholar
• Zuidema, J., Hilbers-Modderman, E.S., and Merkus, F.W., 1986. Clinical pharmacokinetics of dapsone. Clinical Pharmacokinetics, 11(4), 299–315.
   PubMed Web of Science ®Google Scholar